Frequency Electronics (FEIM) Competitors

Eyepoint Pharmaceuticals (NASDAQ:EYPT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Does the media favor EYPT or FEIM?

In the previous week, Eyepoint Pharmaceuticals had 3 more articles in the media than Frequency Electronics. MarketBeat recorded 7 mentions for Eyepoint Pharmaceuticals and 4 mentions for Frequency Electronics. Eyepoint Pharmaceuticals' average media sentiment score of 1.07 beat Frequency Electronics' score of 0.79 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Eyepoint Pharmaceuticals	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Frequency Electronics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of EYPT or FEIM?

99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 4.5% of Eyepoint Pharmaceuticals shares are held by company insiders. Comparatively, 26.1% of Frequency Electronics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more volatility and risk, EYPT or FEIM?

Eyepoint Pharmaceuticals has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500. Comparatively, Frequency Electronics has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500.

Do analysts prefer EYPT or FEIM?

Eyepoint Pharmaceuticals presently has a consensus price target of $26.86, suggesting a potential upside of 131.53%. Given Eyepoint Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts clearly believe Eyepoint Pharmaceuticals is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eyepoint Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
Frequency Electronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better valuation & earnings, EYPT or FEIM?

Frequency Electronics has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eyepoint Pharmaceuticals	$43.27M	18.48	-$130.87M	-$2.68	-4.33
Frequency Electronics	$69.81M	4.57	$23.69M	$2.47	13.28

Is EYPT or FEIM more profitable?

Frequency Electronics has a net margin of 34.09% compared to Eyepoint Pharmaceuticals' net margin of -337.93%. Frequency Electronics' return on equity of 53.83% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eyepoint Pharmaceuticals	-337.93%	-63.80%	-50.72%
Frequency Electronics	34.09%	53.83%	27.82%

Summary

Eyepoint Pharmaceuticals and Frequency Electronics tied by winning 8 of the 16 factors compared between the two stocks.